Skip to main content
Clinical Trials/JPRN-C000000026
JPRN-C000000026CompletedPhase 3

Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401) - Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401)

Japan Clinical Oncology Group(JCOG)0 sites210 target enrollmentStarted: July 22, 2005Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
210

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 79years-old (—)
Sex
Male

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ; 2) mental disease or mental symptoms which would affect participant's decision to participate; 3) continuous medication of steroids (exclude external use of steroids for skin) ; 4) ischemic heart disease or arrhythmia which needs medical treatment; 5) poorly controlled hypertension; 6) poorly controlleddiabetes mellitus; 7) history of cerebral infarction or myocardial infarction within 6 months; 8) liver cirrhosis 9) interstitial pneumonia which requires ventilation assistance, oxygen inhalation, steroids, or diuretic medicine

Investigators

Sponsor
Japan Clinical Oncology Group(JCOG)

Similar Trials